Lilly EVP Ilya Yuffa sells 2,500 shares

ELI LILLY & Co executive Ilya Yuffa reported an insider sale of company stock.

Rhea-AI Filing Summary

ELI LILLY & Co executive Ilya Yuffa reported an insider sale of company stock. On June 10, 2026, Yuffa, EVP & President, LLY USA & Global Capabilities, completed an open-market sale of 2,500 shares of Eli Lilly common stock at an average price of $1,150.77 per share.

The transaction was carried out under a Rule 10b5-1 trading plan that Yuffa adopted on February 13, 2026, indicating it was pre-arranged. Following this sale, he directly holds 29,804.111 shares of Eli Lilly common stock.

Insider Trade Summary 10b5-1

Net Seller: 2,500 shares

Net Sell 1 txn

Insider Yuffa Ilya

Role EVP&Pres, LLY USA&Global Capab

Sold 2,500 shs ($2.88M)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,500	$1,150.77	$2.88M

Holdings After Transaction: Common Stock — 29,804.111 shares (Direct)

Footnotes (1)

1. F1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2026.

Key Figures

Shares sold: 2,500 shares Sale price per share: $1,150.77 per share Shares held after transaction: 29,804.111 shares +2 more

5 metrics

Shares sold 2,500 shares Open-market sale on June 10, 2026

Sale price per share $1,150.77 per share Average price for the 2,500 shares sold

Shares held after transaction 29,804.111 shares Direct ownership following the June 10, 2026 sale

Net shares sold 2,500 shares Net-sell direction in transaction summary

Number of sell transactions 1 transaction Single open-market sale reported in Form 4

Key Terms

Rule 10b5-1 trading plan, open-market sale, Common Stock

3 terms

Rule 10b5-1 trading plan regulatory

"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Eli Lilly (LLY) report for Ilya Yuffa?

Eli Lilly reported that EVP Ilya Yuffa sold 2,500 shares of common stock. The shares were sold in an open-market transaction at an average price of $1,150.77 per share on June 10, 2026, under a pre-arranged Rule 10b5-1 trading plan.

At what price did Ilya Yuffa sell Eli Lilly (LLY) shares?

Ilya Yuffa sold 2,500 Eli Lilly common shares at an average price of $1,150.77. This open-market sale occurred on June 10, 2026, and was executed pursuant to a Rule 10b5-1 trading plan adopted earlier that year.

How many Eli Lilly (LLY) shares does Ilya Yuffa hold after the sale?

After selling 2,500 shares, Ilya Yuffa directly holds 29,804.111 Eli Lilly common shares. This post-transaction ownership reflects his remaining stake as reported in the Form 4 insider filing following the June 10, 2026 open-market sale.

Was Ilya Yuffa’s Eli Lilly (LLY) stock sale under a Rule 10b5-1 plan?

Yes. The filing states the transaction was effected under a Rule 10b5-1 trading plan adopted on February 13, 2026. Such plans allow insiders to schedule trades in advance, helping separate routine portfolio moves from discretionary market-timing decisions.

What role does Ilya Yuffa hold at Eli Lilly (LLY)?

Ilya Yuffa serves as Executive Vice President and President, LLY USA & Global Capabilities. His position makes him a senior officer of Eli Lilly, so his stock transactions must be reported on Form 4, providing transparency into his trading activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yuffa Ilya

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS INDIANA 46285

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP&Pres, LLY USA&Global Capab

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		S(1)		2,500	D	$1,150.77	29,804.111	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2026.

Remarks:

	/s/ Jonathan Groff for Ilya Yuffa, pursuant to authorization on file	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)